Extension of TCR gene-modified T cells to other cancers was afforded by the isolation of a Carcinoembryonic antigen (CEA) specific TCR gene from HLA transgenic mice.8 A partial response was observed in one of three patients treated, and decreases in levels of circulating CEA observed in all patients. The gene discussed is CEACAM5; the disease is cancer.